ExLibris header image
SFX Logo
Title: Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
Source:

Plos One [1932-6203] Chowanadisai, Winyoo yr:2016


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Condello, S. "beta-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids." Oncogene 34.18 (2014): 2297-2308. Link to Full Text for this item Link to SFX for this item
2. Yap, Timothy A., Stan B P. "Beyond chemotherapy: targeted therapies in ovarian cancer." Nature reviews. Cancer 9.3 (2009): 167-181. Link to Full Text for this item Link to SFX for this item
3. Helleday, T. "DNA repair pathways as targets for cancer therapy." Nature reviews. Cancer 8.3 (2008): 193-204. Link to Full Text for this item Link to SFX for this item
4. Hoskins, William J J. "Diagnosis and management of epithelial ovarian cancer." Obstetrics and gynecology 107.6 (2006): 1399-410. Link to SFX for this item
5. Ruggeri, Zaverio M M. "Platelets in atherothrombosis." Nature medicine 8.11 (2002): 1227-34. Link to Full Text for this item Link to SFX for this item
6. Chon, Hye Sook S. "Targeted therapies in gynecologic cancers." Current cancer drug targets 6.4 (2006): 333-63. Link to SFX for this item
7. Hennessy, Bryan T T. "Exploiting the PI3K/AKT pathway for cancer drug discovery." Nature reviews. Drug discovery 4.12: 988-1004. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced